May 9, 2025- McKesson Corporation announced its intention to separate its Medical-Surgical Solutions segment into an independent company (“NewCo”).
McKesson believes a separation will “further enhance the strategic opportunity and operational focus of both companies and unlock value for McKesson shareholders,” the company said. “The separation would advance McKesson and NewCo’s ability to create value for customers, partners, patients, and shareholders.”
McKesson will focus on opportunities that best align with its long-term enterprise strategies, advancing McKesson’s portfolio to focus investment on higher growth, higher margin opportunities in Oncology and Biopharma Solutions.